Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts

Recruiting N/A Interventional Study
Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
200 (estimated)
Sponsor
Tadashi Watabe · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

PET / CT examination using \[18F\] FAPI-74 is performed on patients diagnosed with malignant tumor, and the pathological condition is determined by comparing with FDG-PET/CT examination of conventional diagnostic imaging.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients who meet any of the following conditions. 1. Patients who have been diagnosed with malignant tumors or suspected of having malignant tumors and have CT or FDG-PET examination. 2. Patients who have been diagnosed with malignant tumor and are scheduled to receive or have…
Contacts

Tadashi Watabe, M.D., Ph.D.

+81-6-6879-3461

watabe@tracer.med.osaka-u.ac.jp

CONTACT